Metamizole

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 30.10.2025

Dieser Artikel auf Deutsch

Synonym(s)

Noramidopyrin methanesulfonate

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Pyrazole derivative with strong analgesic, as well as antipyretic, antiphlogistic and spasmolytic effects, which can be used as an intravenously administered alternative to other i.v. injectable non-opioids, if these cannot be used due to severe hepatic (paracetamol) or renal/cardiac risk factors ( parecoxib).

Pharmacodynamics (Effect)This section has been translated automatically.

Predominantly central inhibition of the COX-3 isoenzyme without effect on the constitutionally present COX-1; therefore no gastrointestinal damage!

Undesirable effectsThis section has been translated automatically.

  • Rare: Bone marrow damage with agranulocytosis, severe anaphylactic reactions, drop in blood pressure, hyperhidrosis, possibly red coloration of the urine.
  • Cutaneous NW: described are among others urticaria, angioedema, vasculitis allergica, fixed drug exanthema, erythema exsudativum multiforme, toxic epidermal necrolysis, pustulosis, acute generalized exanthematous (AGEP).

The relative risk of agranulocytosis with metamizole is stated to be between 1.5 and 40.2 (according to the Drug Commission of the German Medical Association). The pathomechanism is unclear; an immunological process is suspected. The reaction is dose-independent. Patients must be informed about the risk of agranulocytosis and the need to seek immediate medical attention in the event of suspicious symptoms (fever, sore throat and inflammation). Due to the risk of this side effect, metamizole is not approved in many countries (Kohn D et al 2025).

PreparationsThis section has been translated automatically.

Novalgin, Analgin, Novamine sulfone

LiteratureThis section has been translated automatically.

  1. Jage J (2009) Key questions on the treatment of postoperative pain. Georg Thieme Verlag, Stuttgart pp.16-21
  2. Kohn D, Wetzig T (2025). Metamizole-induced agranulocytosis. Dtsch Arztebl Int 122: 210b. DOI: 10.3238/arztebl.m2024.0245

Authors

Last updated on: 30.10.2025